LivaNova (LIVN) Shares Outstanding (2014 - 2026)
LivaNova (LIVN) posted Shares Outstanding (Entity) of $55.5 million for Q1 2026, little changed sequentially from $55.5 million in Q4 2025, and little changed YoY from $55.4 million in Q1 2025.
LivaNova (LIVN) Shares Outstanding (2014 - 2026) Analysis & Trends
LivaNova has reported Shares Outstanding (Entity) for 13 years, with the latest figure at $55.5 million in Q1 2026.
- Quarterly Shares Outstanding (Entity) changed 0.17% year-over-year to $55.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $55.5 million (changed 0.17% YoY) and the FY2025 annual result came in at $55.5 million, up 2.02% from the prior year.
- Shares Outstanding (Entity) held at $55.5 million in Q1 2026 per LIVN's latest filing, from $55.5 million in the prior quarter.
- Over five years, Shares Outstanding (Entity) peaked at $55.5 million in Q1 2026 and troughed at $53.8 million in Q1 2022.
- A 5-year average of $54.5 million and a median of $54.3 million in 2024 frame the typical range for Shares Outstanding (Entity).
- The widest YoY moves for Shares Outstanding (Entity): up 8.71% in 2022, down 0.15% in 2022.
- Over 5 years, Shares Outstanding (Entity) stood at $53.9 million in 2022, then rose by 0.17% to $53.9 million in 2023, then increased by 0.92% to $54.4 million in 2024, then climbed by 2.02% to $55.5 million in 2025, then increased by 0.0% to $55.5 million in 2026.
- According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $55.5 million, $55.5 million, and $55.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.77 Bn | 194.17 Bn | 7.27 Bn | 1.74 Bn |
| 2 | Stryker | 129.56 Bn | 126.08 Bn | 4.50 Bn | 383.50 Mn |
| 3 | Medtronic | 120.09 Bn | 110.87 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 73.80 Bn | 73.26 Bn | 3.85 Bn | 1.47 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 576.40 Mn |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn | 382.20 Mn |
| 7 | GE HealthCare Technologies | 34.10 Bn | 31.99 Bn | 2.18 Bn | 453.00 Mn |
| 8 | Koninklijke Philips | 26.45 Bn | 23.12 Bn | 4.55 Bn | 955.57 Mn |
| 9 | Steris | 23.20 Bn | 22.72 Bn | 684.20 Mn | 97.60 Mn |
| 10 | LivaNova | 4.35 Bn | 3.83 Bn | 273.67 Mn | 54.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 54.97 Mn |
| Mar 31, 2026 | 54.69 Mn |
| Dec 31, 2025 | 54.55 Mn |
| Sep 30, 2025 | 54.63 Mn |
| Jun 30, 2025 | 54.58 Mn |
| Mar 31, 2025 | 54.42 Mn |
| Dec 31, 2024 | 54.24 Mn |
| Sep 30, 2024 | 54.35 Mn |
| Jun 30, 2024 | 54.24 Mn |
| Mar 31, 2024 | 54.01 Mn |
| Dec 31, 2023 | 53.94 Mn |
| Sep 30, 2023 | 53.99 Mn |
| Jun 30, 2023 | 53.80 Mn |
| Mar 31, 2023 | 53.62 Mn |
| Dec 31, 2022 | 53.47 Mn |
| Sep 30, 2022 | 53.53 Mn |
| Jun 30, 2022 | 53.51 Mn |
| Mar 31, 2022 | 53.30 Mn |
| Dec 31, 2021 | 50.63 Mn |
| Sep 30, 2021 | 51.58 Mn |